Subdural effusion associated with COVID-19 encephalopathy: A case report.
Brain fog
COVID-19 encephalopathy
Case report
Cerebral infarction
Hemorrhagic transformation
Novel coronavirus infection
Subdural effusion
Journal
World journal of clinical cases
ISSN: 2307-8960
Titre abrégé: World J Clin Cases
Pays: United States
ID NLM: 101618806
Informations de publication
Date de publication:
06 Apr 2024
06 Apr 2024
Historique:
received:
16
11
2023
revised:
07
01
2024
accepted:
08
03
2024
medline:
25
4
2024
pubmed:
25
4
2024
entrez:
25
4
2024
Statut:
ppublish
Résumé
The precise mechanism by which severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) impacts the central nervous system remains unclear, with manifestations spanning from mild symptoms ( A 56-year-old male patient presented with left-sided limb weakness and slurred speech as predominant clinical symptoms. Through comprehensive imaging and diagnostic assessments, he was diagnosed with cerebral infarction complicated by hemorrhagic transformation affecting the right frontal, temporal, and parietal regions. In addition, an intracranial infection with SARS-CoV-2 was identified during the rehabilitation process; consequently, an idiopathic subdural effusion developed. Remarkably, the subdural effusion underwent absorption within 6 d, with no recurrence observed during the 3-month follow-up. Subdural effusion is a potentially rare intracranial complication associated with SARS-CoV-2 infection.
Sections du résumé
BACKGROUND
BACKGROUND
The precise mechanism by which severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) impacts the central nervous system remains unclear, with manifestations spanning from mild symptoms (
CASE SUMMARY
METHODS
A 56-year-old male patient presented with left-sided limb weakness and slurred speech as predominant clinical symptoms. Through comprehensive imaging and diagnostic assessments, he was diagnosed with cerebral infarction complicated by hemorrhagic transformation affecting the right frontal, temporal, and parietal regions. In addition, an intracranial infection with SARS-CoV-2 was identified during the rehabilitation process; consequently, an idiopathic subdural effusion developed. Remarkably, the subdural effusion underwent absorption within 6 d, with no recurrence observed during the 3-month follow-up.
CONCLUSION
CONCLUSIONS
Subdural effusion is a potentially rare intracranial complication associated with SARS-CoV-2 infection.
Identifiants
pubmed: 38660075
doi: 10.12998/wjcc.v12.i10.1799
pmc: PMC11036469
doi:
Types de publication
Case Reports
Langues
eng
Pagination
1799-1803Informations de copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Déclaration de conflit d'intérêts
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.